Cargando…
Non-coding RNAs as Putative Biomarkers of Cancer-Associated Cachexia
Cachexia is a complex metabolic syndrome that determines a severe body weight loss characterized by a marked reduction in muscle mass. About 80% of patients with advanced cancer develop cachexia due to both the tumor itself and cancer treatment (radiotherapy and/or chemotherapy), which is associated...
Autores principales: | Donzelli, Sara, Farneti, Alessia, Marucci, Laura, Ganci, Federica, Sacconi, Andrea, Strano, Sabrina, Sanguineti, Giuseppe, Blandino, Giovanni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187787/ https://www.ncbi.nlm.nih.gov/pubmed/32373612 http://dx.doi.org/10.3389/fcell.2020.00257 |
Ejemplares similares
-
microRNAs: short non-coding bullets of gain of function mutant p53 proteins
por: Donzelli, Sara, et al.
Publicado: (2014) -
Regulation of Skeletal Muscle Atrophy in Cachexia by MicroRNAs and Long Non-coding RNAs
por: Chen, Rui, et al.
Publicado: (2020) -
MicroRNAs: short non-coding players in cancer chemoresistance
por: Donzelli, Sara, et al.
Publicado: (2014) -
The miR-205-5p/BRCA1/RAD17 Axis Promotes Genomic Instability in Head and Neck Squamous Cell Carcinomas
por: Valenti, Fabio, et al.
Publicado: (2019) -
MicroRNA-181a/b: Novel biomarkers to stratify breast cancer patients for PARPi treatment
por: Mori, Federica, et al.
Publicado: (2013)